InsiderTrades.com logo

ANL Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $131.80

Adlai Nortye Insider Trading History Chart

This chart shows the insider buying and selling history at Adlai Nortye by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Adlai Nortye Share Price & Price History

Current Price: $11.93
Price Change: ▲ Price Increase of +0.573 (5.04%)
As of 05/21/2026 02:07 PM ET

This chart shows the closing price history over time for ANL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Adlai Nortye Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/13/2026Yang LuCEOSell10$13.18$131.8099,990View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Adlai Nortye (NASDAQ:ANL)

35.21% of Adlai Nortye stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ANL by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Adlai Nortye Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/18/2026ADAR1 Capital Management LLC117,909$0.82M0.0%N/A0.295%Search for SEC Filing on Google Icon
5/15/2026Affinity Asset Advisors LLC164,748$1.14M0.1%N/A0.412%Search for SEC Filing on Google Icon
5/14/2026Renaissance Technologies LLC66,000$0.46M0.0%N/A0.165%Search for SEC Filing on Google Icon
4/21/2026SmartHarvest Portfolios LLC16,367$0.11M0.0%+8.5%0.044%Search for SEC Filing on Google Icon
2/15/2024Cantor Fitzgerald L. P.40,310$0.36M0.1%+128.2%0.109%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Adlai Nortye logo
Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trial for the treatment of recurrent or metastatic head and neck squamous cell carcinomas. The company is also developing AN0025, a small molecule prostaglandin E receptor 4 antagonist to modulate the tumor microenvironment that is in a Phase Ib clinical trial for the treatment of recurrent non-small cell lung cancer and urothelial cancer after anti-PD-1/PD-L1 treatments, recurrent triple-negative breast cancer, microsatellite stable colorectal cancer, and cervical cancer after standard of care treatments; and AN4005, an oral small-molecule PD-L1 inhibitor, which is in Phase I clinical trial to induce and stabilize PD-L1 dimerization and thereby disrupt the interaction between PD-1 and PD-L1. Its preclinical candidates include AN8025, a multifunctional antibody as T cell and antigen-presenting cell modulator; AN1025, an oral small molecule degrader of ß-catenin; and AN9025, an oral small molecule pan-KRAS inhibitor. The company was founded in 2004 and is based in Grand Cayman, the Cayman Islands.
Read More on Adlai Nortye

Today's Range

Now: $11.93
Low: $11.34
High: $12.13

50 Day Range

MA: $11.18
Low: $6.46
High: $16.60

52 Week Range

Now: $11.93
Low: $0.88
High: $17.25

Volume

56,896 shs

Average Volume

550,254 shs

Market Capitalization

$477.32 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.23

Who are the company insiders with the largest holdings of Adlai Nortye?

Adlai Nortye's top insider shareholders include:
  1. Yang Lu (CEO)
Learn More about top insider investors at Adlai Nortye.

Who are the major institutional investors of Adlai Nortye?

Adlai Nortye's top institutional shareholders include:
  1. Affinity Asset Advisors LLC — 0.41%
  2. ADAR1 Capital Management LLC — 0.29%
  3. Renaissance Technologies LLC — 0.17%
  4. SmartHarvest Portfolios LLC — 0.04%
Learn More about top institutional investors of Adlai Nortye stock.

Which major investors are buying Adlai Nortye stock?

Within the previous quarter, ANL stock was acquired by institutional investors including:
  1. Affinity Asset Advisors LLC
  2. ADAR1 Capital Management LLC
  3. Renaissance Technologies LLC
  4. SmartHarvest Portfolios LLC